Research
- Research Topics
- Cell Biology and Tumor Biology
- Stem Cells and Cancer
- Inflammatory Stress in Stem Cells
- Experimental Hematology
- Molecular Embryology
- Signal Transduction and Growth Control
- Epigenetics
- Redox Regulation
- Vascular Oncology and Metastasis
- Clinical Neurobiology
- Molecular Neurogenetics
- Chaperones and Proteases
- Vascular Signaling and Cancer
- Molecular Neurobiology
- Mechanisms Regulating Gene Expression
- Molecular Biology of Centrosomes and Cilia
- Dermato-Oncology
- Pediatric Leukemia
- Molecular Hematology - Oncology
- Cancer Progression and Metastasis
- Metastatic Niches
- Molecular Leukemogenesis
- DNA Repair Mechanisms and Cancer
- Neuronal Signaling and Morphogenesis
- Cell Signaling and Metabolism
- Cell Fate Engineering and Disease Modeling
- Cancer Drug Development
- Cell Morphogenesis and Signal Transduction
- Tumour Metabolism and Microenvironment
- Helmholtz Professorship Cell Biology
- Functional and Structural Genomics
- Molecular Genome Analysis
- Molecular Genetics
- Pediatric Neurooncology
- Cancer Genome Research
- Chromatin Networks
- Functional Genome Analysis
- Theoretical Systems Biology
- Neuroblastoma Genomics
- Signaling and Functional Genomics
- Signal Transduction in Cancer and Metabolism
- RNA Biology and Cancer
- Systems Biology of Signal Transduction
- Molecular thoracic Oncology
- Proteomics of Stem Cells and Cancer
- Computational Genomics and System Genetics
- Regulatory Genomics and Cancer Evolution
- Applied Functional Genomics
- Applied Bioinformatics
- Translational Medical Oncology
- Cancer Epigenomics
- Translational Pediatric Sarcoma Research
- Neuropathology
- Pediatric Oncology
- Neurooncology
- Somatic Evolution and Early Detection
- Translational Control and Metabolism
- Pediatric Glioma Research
- Soft-Tissue Sarcoma
- Precision Sarcoma Research
- Neural Stem Cell Genome Integrity in Brain Development and Diseases
- Mechanisms of Leukemogenesis
- Genome Instability in Tumors
- Developmental Origins of Pediatric Cancer
- Brain Tumor Translational Targets
- Brain Cancer Metabolism
- Translational Functional Cancer Genomics
- SPRINT
- Cancer Risk Factors and Prevention
- Cancer Epidemiology
- Biostatistics
- Clinical Epidemiology and Aging Research
- Health Economics
- Physical Activity, Prevention and Cancer
- Preventive Oncology
- Digital Biomarkers for Oncology
- Genomic Epidemiology
- Cancer Survivorship
- Molecular Epidemiology
- Immunology and Cancer
- Cellular Immunology
- Molecular Oncology of Gastrointestinal Tumors
- Translational Immunotherapy
- B Cell Immunology
- Immune Diversity
- Structural Biology of Infection and Immunity
- Applied Tumor-Immunity
- Neuroimmunology and Brain Tumor Immunology
- T Cell Metabolism
- Adaptive Immunity and Lymphoma
- Immune Regulation in Cancer
- GMP & T Cell Therapy
- News
- Imaging and Radiooncology
- Radiology
- Research
- Computational Radiology Research Group
- Contrast Agents In Radiology Research Group
- Neuro-Oncologic Imaging Research Group
- Radiological Early Response Assessment Of Modern Cancer Therapies
- Imaging In Monoclonal Plasma Cell Disorders
- 7 Tesla MRI - Novel Imaging Biomarkers
- Functional Imaging
- Visualization And Forensic Imaging
- PET/MRI
- Dual- and Multienergy CT
- Radiomics Research Group
- Prostate Research Group
- Breast Imaging Research Group
- Bone marrow
- Musculoskeletal Imaging
- Staff
- Patients
- Research
- Medical Physics in Radiology
- X-Ray Imaging and Computed Tomography
- Medical Informatics for Translational Oncology
- Federated Information Systems
- Medical Physics in Radiation Oncology
- Biomedical Physics in Radiation Oncology
- Computer Assisted Medical Interventions
- Medical Image Computing
- Radiooncology - Radiobiology
- Radiation Oncology
- Molecular Radiooncology
- Nuclear Medicine
- Medical Imaging and Radiology - Cancer Prevention
- Molecular Biology of Systemic Radiotherapy
- Translational Radiation Oncology
- Molecular Mechanisms of Head and Neck Tumors
- Radiology
- Infection, Inflammation and Cancer
- Tumor Virology
- Viral Transformation Mechanisms
- Pathogenesis of Virus-Associated Tumors
- Applied Tumor Biology
- Virotherapy
- Virus-associated Carcinogenesis
- Chronic Inflammation and Cancer
- Microbiome and Cancer
- Cell Plasticity and Epigenetic Remodeling
- Cellular Polarity and Viral Infection
- Noroviruses
- Laboratory of Oncolytic Virus Immuno-Therapeutics
- Infections and Cancer Epidemiology
- Tumorvirus-specific Vaccination Strategies
- Mammalian Cell Cycle Control Mechanisms
- Molecular Therapy of Virus-Associated Cancers
- Immunotherapy and Immunoprevention - Molecular Vaccine Design
- DNA Vectors
- Episomal-Persistent DNA in Cancer- and Chronic Diseases
- Other Units
- Cell Biology and Tumor Biology
- Research Groups A-Z
- Junior Research Groups
- Core Facilities
- Center for Preclinical Research
- Chemical Biology Core Facility
- Electron Microscopy
- Flow Cytometry
- Genomics and Proteomics
- Information Technology
- Library
- Kataloge - Catalogues
- Zeitschriften - Journals
- E-Books - Ebooks
- Datenbanken - Databases
- Dokument-Lieferung - Document Delivery
- Publikationsdatenbank - Publication database
- DKFZ Archiv - DKFZ Archive
- Open Access
- Science 2.0
- Ansprechpartner - Contact
- More Information - Service
- Anschrift - Address
- Antiquariat - Second Hand
- Aufstellungssystematik - Shelf Classification
- Ausleihe - Circulation
- Benutzerhinweise - Library Use
- Beschaffungsvorschläge - Desiderata
- Fakten und Zahlen - Facts and Numbers
- Kooperationen, Konsortien - Cooperations, Consortia
- Kopieren, Scannen - Copying, Scans
- Kurse, Führungen - Courses, Introductions
- Öffnungszeiten - Opening Hours
- DEAL-Info
- DKFZ-Intern - internal only
- Light Microscopy
- Omics IT and Data Management Core Facility
- Small Animal Imaging
- Metabolomics Core Technology Platform
- Data Science @ DKFZ
- INFORM
- Databox
- Baden-Württemberg Cancer Registry
- Cooperations & Networks
- National Cooperations
- International Cooperations
- Cooperational Research Program with Israel: DKFZ - MOST in Cancer Research
- Program
- Members of the Program Committee
- Call 2019
- Publication Database
- German-Israeli Cancer Research Schools
- Archive
- Heidelberg - Israel, Science and Culture
- Symposium 40 Years of German-Israeli Cooperation
- 35th Anniversary Symposium
- 34th Meeting of the DKFZ-MOST Program
- 40th Anniversary Publication
- 30th Anniversary Publication
- 20th Anniversary Publication
- Flyer - The Cancer Cooperation Program
- List Publications 1976-2004
- Highlight-Projects
- Cooperational Research Program with Israel: DKFZ - MOST in Cancer Research
- Cooperations with industrial companies
- Helmholtz Alliances
- DKFZ PostDoc Network
- Cross Program Topic RNA@DKFZ
- Cross Program Topic Epigenetics@dkfz
- Cross Program Topic Single Cell Sequencing
- WHO Collaborating Centers
- DKFZ Site Dresden
High-throughput screen for novel apoptosis-inducing substances for CLL
Even though most CLL patients respond to currently available chemo- or immunotherapies with a profound reduction in tumor burden, relapse of disease and subsequent resistance to therapy is frequent and often associated with clonal evolution of CLL cells. This is mainly due to the fact that quiescent CLL cells within the peripheral blood are effectively eliminated, but malignant cells within protective microenvironments like in the lymph nodes or bone marrow are less effectively targeted by the therapeutics. Therefore, novel drug screening approaches using CLL coculture systems that mimic the protective in vivo microenvironment are necessary to identify substances that are able to overcome this protection. The CLL/stroma coculture models we have established are very well suited for such testing. As they allow for a simultaneous monitoring of effects on CLL cells and stromal cells, general cytotoxic substances can be excluded.
Fungal extracts have been shown to be an important source for biologically active agents, which can be of therapeutic use. In cooperation with Prof. Thomas Larsen we are screening for novel potential drugs for CLL by using an extensive extract library from the IBT Culture Collection of Fungi (Technical University of Denmark) in a high-throughput coculture set-up of primary CLL cells. Chaetoglobosin A was identified as the active compound of one of the most promising hits of this screen. Functional studies revealed that this substance induces apoptosis preferentially in CLL cells, most likely by impacting on cytoskeleton-dependent signalling pathways (see Knudsen et al., 2013). We are in the process of testing the efficacy of Chaetoglobosin A in a murine animal model for CLL, the Eµ-TCL1 transgenic mice, as well as in xenotransplants of human CLL cells in immunodeficient mice (see CLL mouse models).
In addition, further identification and characterization of active substances within fungal extracts that showed CLL-specific cytotoxic activities are ongoing.
The IBT fungal culture collection was used to screen for novel potential drugs for CLL. Thereby, Chaetoglobosin A (ChA) was identified as the active compound within Penicillium aquamarinium extracts, and confirmed to have preferential cytotoxic activity for CLL cells compared to healthy donor lymphocytes (HD). Results of functional studies suggest that Chaetoglobosin A disrupts pro-survival signalling and migration of CLL cells by inhibiting actin filament formation.